InMed Pharmaceuticals Inc INM

Healthcare Cannabis

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

NDAQ:INM - Post by User

InMed Pharmaceuticals Inc > From the Inmed FB page

<< Previous

Bullboard Posts

Next >>

Comment by MeanGreenon Jul 01, 2021 12:45pm

139 Views

Post# 33479415

RE:From the Inmed FB page

He Is owns a lot of shares in the company and I think that's as far as his interest in the company goes. I'm sure he would be open to a conversation with you if you posted on that board rather than this one.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?